Shen Hong, Stacey Brandon R, Applegate Robert J, Zhao David, Gandhi Sanjay K, Kon Neal D, Kincaid Edward H, Pu Min
Section on Cardiovascular Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Shanghai Jiao Tong University, Sixth People's Hospital, Shanghai, China.
Echocardiography. 2020 Jan;37(1):14-21. doi: 10.1111/echo.14561.
This study was to evaluate the prognostic significance of low gradient severe aortic stenosis (LG SAS) and preserved left ventricular ejection fraction (LVEF) with the integration of echocardiographic and clinical data.
The study included 172 patients with LG SAS (AVAi ≤ 0.6 cm /m , mean aortic pressure gradient < 40 mm Hg) and LVEF (≥ 50%). LV outflow tract diameters were measured at both the aortic valve annulus and 5 mm below the annulus for the measurement consistency. Patients were divided into the low flow LG SAS (LF/LG SAS: SVi < 35mL/m and AVAi ≤ 0.6 cm /m ) and normal-flow LG SAS groups (NF/LG SAS: SVi ≥ 35mL/m and AVAi ≤ 0.6 cm /m ). Echocardiographic findings and clinical data were systematically analyzed with mean follow-up of 3.0 ± 1.6 years.
LF/LG SAS had significantly smaller AVAi, lower SVi, a higher prevalence of atrial fibrillation (28% vs 12% P = .01) and diabetes (47% vs 27% P = .007) and lower 3-year cumulative survival than NF/LG SAS. Multivariable analysis showed that dyspnea, renal dysfunction (CI 1.42-3.99, P < .01), left atrial diameter, and SVi were independently associated with an increased risk for all-cause mortality. Aortic valve intervention (AVI) improved survival in LF/LG SAS (68% vs 48%, P < .05) in comparison with medical management (HR: 4.20, CI: 1.12-15.76, P = .03), but only modestly in NF/LG SAS (75% vs 65% P > .05).
Outcome of LG SAS was independently associated with clinical characteristics. AVI likely improved outcome of LF/LG SAS who had high-risk clinical characteristics and unfavorable echocardiographic findings.
本研究旨在结合超声心动图和临床数据,评估低跨瓣压差严重主动脉瓣狭窄(LG SAS)及左心室射血分数(LVEF)保留的预后意义。
本研究纳入172例LG SAS(有效瓣口面积指数[AVAi]≤0.6 cm²/m²,平均主动脉瓣压差<40 mmHg)且LVEF≥50%的患者。在主动脉瓣环及瓣环下方5 mm处测量左心室流出道直径,以确保测量的一致性。患者被分为低流量LG SAS组(LF/LG SAS:每平方米体表面积的每搏量[SVi]<35 mL/m²且AVAi≤0.6 cm²/m²)和正常流量LG SAS组(NF/LG SAS:SVi≥35 mL/m²且AVAi≤0.6 cm²/m²)。对超声心动图检查结果和临床数据进行系统分析,平均随访时间为3.0±1.6年。
LF/LG SAS组的AVAi显著更小,SVi更低,房颤患病率更高(28%对12%,P = 0.01),糖尿病患病率更高(47%对27%,P = 0.007),3年累积生存率低于NF/LG SAS组。多变量分析显示,呼吸困难、肾功能不全(置信区间1.42 - 3.99,P < 0.01)、左心房直径和SVi与全因死亡风险增加独立相关。与药物治疗相比,主动脉瓣介入治疗(AVI)改善了LF/LG SAS组的生存率(68%对48%,P < 0.05)(风险比:4.20,置信区间:1.12 - 15.76,P = 0.03),但在NF/LG SAS组仅略有改善(75%对65%,P > 0.05)。
LG SAS的预后与临床特征独立相关。AVI可能改善了具有高危临床特征和不良超声心动图表现的LF/LG SAS患者的预后。